1-Ethynylcyclohexanol → 10-((1-hydroxycyclohexyl)ethynyl)-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide
반응식
Br[C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[C:12]([C:18]([NH:20][CH3:21])=[O:19])=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=[C:7]3[C:6]=2[CH:22]=1.[C:23]([C:25]1([OH:31])[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1)#[CH:24]>>[OH:31][C:25]1([C:23]#[C:24][C:2]2[CH:3]=[CH:4][C:5]3[O:11][CH2:10][CH2:9][N:8]4[C:12]([C:18]([NH:20][CH3:21])=[O:19])=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=[C:7]4[C:6]=3[CH:22]=2)[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1참가 물질
3
실험 절차
Similar to as described in General Procedure E, reaction of 10-bromo-N3-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2,3-dicarboxamide with 1-ethynylcyclohexanol gave the titled compound. M+H=409.2.
출처 및 근거
- ORD 기록
- ord-9dd1ca529126497591ff5fbf32bea9f8
- 출처 데이터셋
- uspto-grants-2015_05
- 특허 번호
- US09034866B2
반응 노트
불러오는 중…